IDEXX Laboratories (BSP:I1DX34) Accounts Payable & Accrued Expense : R$2,281 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Accounts Payable & Accrued Expense?

IDEXX Laboratories's quarterly accounts payable & accrued expense increased from Sep. 2023 (R$1,753 Mil) to Dec. 2023 (R$1,936 Mil) and increased from Dec. 2023 (R$1,936 Mil) to Mar. 2024 (R$2,281 Mil).

IDEXX Laboratories's annual accounts payable & accrued expense declined from Dec. 2021 (R$2,105 Mil) to Dec. 2022 (R$1,996 Mil) and declined from Dec. 2022 (R$1,996 Mil) to Dec. 2023 (R$1,936 Mil).

IDEXX Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for IDEXX Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Accounts Payable & Accrued Expense Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,037.02

1,568.23

2,104.71

1,995.69

1,936.29

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,037.89	1,756.05	1,752.61	1,936.29	2,281.17

IDEXX Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines